Medical Properties Trust, Inc. (MPT) Stock Price & Analysis
Medical Properties Trust, Inc. (MPT) closed at USD 2.71 on Thursday, October 22, 2026, up 3.04% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 2.63; the Oct 22, 2026 session ranged USD 2.61–2.73 on volume of 16,858,603 shares. Market capitalization is $1.62B, with a 52-week range of USD 2.61–6.47 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 11:03 UTC.
Also available as compact Markdown for AI agents: nexqual.com/MPT.md
Key facts (MPT)
- Last four reported quarters (through Jun 30, 2026): revenue $1.02B, net income -$30.2M (-3.0% margin) (SEC filings).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $10K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.75 on a 1–5 scale) (8 analysts), mean target USD 5.13 (range 4.25–7).
- Total return with dividends: 1Y -42.1% vs S&P 500 +14.9%; 5Y -79.8% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0, revenue estimate $263M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MPT)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.54B | $872M | $996M | $972M | $1.02B |
| Gross profit | $1.44B | $1.38B | $762M | $921M | $882M | — |
| Net income | $656M | $903M | -$556M | -$2.41B | -$277M | -$30.2M |
| EPS (diluted) | $1.11 | $1.50 | -$0.93 | -$4.02 | -$0.46 | — |
| Gross margin | 93.4% | 89.1% | 87.4% | 92.6% | 90.7% | — |
| Net margin | 42.5% | 58.5% | -63.8% | -242.1% | -28.5% | -3.0% |
| Revenue growth | +23.6% | -0.1% | -43.5% | +14.2% | -2.4% | — |
| Cash + short-term investments | $459M | $236M | $250M | $332M | $541M | — |
| Total debt | $11.3B | $10.3B | $10.1B | $8.85B | $9.70B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (MPT)
P/S 1.6x · EV/Sales 10.7x · P/B 0.4x · Earnings yield -1.87% · Net debt $9.31B · EV $10.9B
Insider purchases (SEC Form 4, open-market, last ~7 months) (MPT)
1 purchase, $10K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-08-20 | Hanna James Kevin | Senior VP, Controller & CAO | 2,300 | $10K | 4.15 | Too little history (no open-market trades in 2023) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (MPT)
Consensus Hold (mean 2.75 on a 1–5 scale), 8 analysts; mean target USD 5.13 (low 4.25, high 7).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-01 | Wells Fargo | Target lowered | Underweight | $5 → $3.8 |
Total return (dividends reinvested) (MPT)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -42.1% | -79.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -42.2% | -27.3% |
| Volatility (annualized) | 37.7% | 50.8% |
| Max drawdown | -53.6% (Feb 2026→Oct 2026) | -84.5% (Jan 2022→Jan 2024) |
MPT suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Prospect Medical Holdings | “Over the next twelve months, we expect our monthly rent and interest receipts to increase with our contractually required annual escalations, from the ramp up of cash rents from certain of the tenants that last year replaced Steward, and expected ramping up of rent revenue from the replacement tenant of the six Prospect California facilities.” |
| Partner | Steward Healthcare | “In 2024, we recognized $1.8 billion of real estate and other impairment charges and negative fair value adjustments, primarily associated with our investments in Steward, Prospect, and the international joint venture.” |
| Partner | NOR Healthcare Systems | “the ability of our tenants, operators, and borrowers (including those of our joint ventures) to satisfy their obligations under their respective contractual arrangements with us, including tenants (like Healthcare Systems of America ("HSA") and NOR Healthcare Systems ("NOR")) that have rents that will ramp up in 2026;” |
| Partner | Lifepoint Health | “During 2025, we completed construction, and began recording rental income, on three projects totaling approximately $46.5 million, two of which are leased to Lifepoint Behavioral and the other to Surgery Partners.” |
Quoted from the company's 10-K filed Feb 26, 2026.
MPT company outlook (results filed Aug 10, 2026)
- “During the quarter, the Company advanced an additional $50 million for working capital purposes to HSA, of which $20 million has been repaid and an additional $20 million is expected to be repaid in August.”
- “FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time.”
Quoted word-for-word from the SEC 8-K results press release.
MPT analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.00 | $0.04 | -100.0% | $262.5M | 1 |
| Next quarter (ends Dec 2026) | $0.00 | $0.04 | -100.0% | $264.0M | 1 |
| Current fiscal year (ends Dec 2026) | $0.10 | $0.13 | -16.7% | $1.04B | 2 |
| Next fiscal year (ends Dec 2027) | $0.05 | $0.15 | -65.9% | $1.08B | 2 |
MPT options: expected move
Options price a move of about ±15.4% (±$0.42) by Oct 30, 2026, which includes earnings on Oct 29, 2026. Over the last 8 reports the stock moved ±8.2% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 123.4% | ±15.4% |
| Nov 6, 2026 | 14 | 107.2% | ±17.8% |
| Nov 13, 2026 | 21 | 90.5% | ±18.2% |
| Nov 20, 2026 | 28 | 85.3% | ±19.5% |
| Nov 27, 2026 | 35 | 75.9% | ±19.3% |
| Dec 18, 2026 | 56 | 64.3% | ±21.2% |
| Jan 15, 2027 | 84 | 68.5% | ±25.8% |
| Mar 19, 2027 | 147 | 59.9% | ±29.7% |
30-day implied volatility 65.8% vs 45.3% realized over the last 30 trading days. Put/call ratio (volume) 1.27. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 11:03 UTC)
| Price | USD 2.71 |
|---|---|
| Change | ▲ 3.04% (up) |
| Previous Close | USD 2.63 |
| Open | USD 2.62 |
| Day Range | USD 2.61 – 2.73 |
| 52-Week Range | USD 2.61 – 6.47 |
| Volume | 16,858,603 shares |
| Market Cap | $1.62B |
| Exchange | NYQ |
Technical Analysis (MPT)
Nexqual's technical model rates MPT "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 11:03 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 22.53 (oversold) |
| vs SMA50 | Below (USD 3.6) |
| MACD | -0.25 (negative) |
Analyst Ratings (MPT)
Wall Street analysts rate MPT "Hold" based on 8 analysts, with a mean price target of USD 5.13 (range USD 4.25–7), per Nexqual as of October 23, 2026 at 11:03 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 5.13 |
| High Target | USD 7 |
| Low Target | USD 4.25 |
| Buy / Hold / Sell | 3 / 3 / 2 |
Earnings (MPT)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 0 |
| Revenue Estimate | $262.54M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.01 vs est 0 ▲ beat |
| 2026-03-31 | USD 0.09 vs est 0.01 ▲ beat |
| 2025-12-31 | USD 0.07 vs est 0 ▲ beat |
| 2025-09-30 | USD -0.13 vs est 0.02 ▼ miss |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Financials & Fundamentals (MPT)
| Total Revenue | $1.10B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +1.90% |
| Gross Margin | +95.94% |
| Operating Margin | +57.36% |
| Profit Margin | -2.73% |
| ROE | -0.62% |
| Debt / Equity | 2.16 |
| Current Ratio | 1.17 |
| Total Cash | $396.56M |
| Total Debt | $9.70B |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Financial Health Score (MPT)
Nexqual rates Medical Properties Trust, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 11:03 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Strong — Operating margin 57% |
| Balance Sheet | Weak — $397M cash and investments vs $9.70B debt (Jun 2026, SEC) |
| Cash Flow | Solid — Operating cash flow $231M (FY ended Dec 2025, 10-K) |
| Efficiency | Critical — ROE -1%, ROA 2.8% |
Ownership (MPT)
| Insider Ownership | +8.78% |
|---|---|
| Institutional Ownership | +61.83% |
| Shares Outstanding | 597.20M |
| Float | 489.92M |
| Short % of Float | +32.76% |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
Leadership (MPT)
Medical Properties Trust, Inc. is led by Edward K. Aldag, Founder, Chairman, President & CEO, per Nexqual as of October 23, 2026 at 11:03 UTC.
| Founder, Chairman, President & CEO | Edward K. Aldag |
|---|---|
| Founder, Executive VP, CFO & Director | R. Steven Hamner |
Major Backers & Investors (MPT)
Notable institutional backers of Medical Properties Trust, Inc. include AQR Capital Management, LLC, Charles Schwab Investment Management, Inc., Two Sigma Investments, LP, according to Nexqual as of October 23, 2026 at 11:03 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AQR Capital Management, LLC | 2.95% |
| Charles Schwab Investment Management, Inc. | 1.93% |
| Two Sigma Investments, LP | 1.22% |
| DEUTSCHE DWS INVESTMENT TRUST-DWS Core Equity Fund | 0.84% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 12.6% |
| Vanguard Group | 10.97% |
| State Street | 4.21% |
| Geode Capital | 1.67% |
| Northern Trust | 1.24% |
| Allianz Asset Management GmbH | 1.23% |
Source: Nexqual, October 23, 2026 at 11:03 UTC.
From Medical Properties Trust, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Partnerships
- Violations may also result in civil sanctions, including civil monetary penalties of up to $50,000 per violation, exclusion from participation in federal healthcare programs, including Medicare and Medicaid, and additional monetary penalties in amounts treble to the underlying remuneration.
- In regard to our real estate partnership with Macquarie Asset Management ("Macquarie"), the bankruptcy court approved the termination of the partnership's master lease with Steward during the 2024 third quarter.
Legal & Regulatory Risks (Item 1A, quoted)
- Our tenants are subject to fraud and abuse laws, the violation of which may jeopardize their ability to make payments to us and adversely affect their profitability.
- We may incur substantial capital expenditures to make our healthcare facilities suitable for tenants or compliant with applicable regulatory requirements.
- Regulatory restrictions on healthcare transactions involving REITs could adversely affect our business, results of operations, and financial condition.
- Unfavorable resolution of pending and future litigation, regulatory proceedings, or governmental inquiries could have a material adverse effect on our and our tenants' business, results of operations, financial condition, and reputation.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DHC | Diversified Healthcare Trust | USD 7.87 | ▲ 2.34% |
| LTC | LTC Properties, Inc. | USD 43.33 | ▲ 2.7% |
| NHI | National Health Investors, Inc. | USD 66.96 | ▲ 3.14% |
| UHT | Universal Health Realty Income | USD 37.81 | ▲ 2.41% |
| SBRA | Sabra Health Care REIT, Inc. | USD 19.6 | ▲ 3.7% |
| XRN | Chiron Real Estate Inc. | USD 30.16 | ▲ 4.61% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 11:03 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt